Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
IQV Stock Forecast 2026-2027
$176.46
Current Price
$29.95B
Market Cap
Buy 21
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to IQV Price Targets
+62.6%
To High Target of $287.00
+29.8%
To Median Target of $229.00
+4.8%
To Low Target of $185.00
IQV Price Momentum
+0.7%
1 Week Change
+6.3%
1 Month Change
+25.0%
1 Year Change
-21.7%
Year-to-Date Change
-28.6%
From 52W High of $247.05
+31.1%
From 52W Low of $134.65
📊 TOP ANALYST CALLS
Did IQV Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if IQVIA is one of their latest high-conviction picks.
Latest IQV Stock Price Targets & Analyst Predictions
Based on our analysis of 44 Wall Street analysts, IQV has a bullish consensus with a median price target of $229.00 (ranging from $185.00 to $287.00). The overall analyst rating is Strong Buy (9.2/10). Currently trading at $176.46, the median forecast implies a 29.8% upside. This outlook is supported by 21 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Luke Sergott at Barclays, projecting a 62.6% upside. Conversely, the most conservative target is provided by Elizabeth Anderson at Evercore ISI Group, suggesting a 4.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
IQV Analyst Ratings
21
Buy
2
Hold
0
Sell
IQV Price Target Range
Low
$185.00
Average
$229.00
High
$287.00
Current: $176.46
Latest IQV Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for IQV.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 8, 2026 | Evercore ISI Group | Elizabeth Anderson | Outperform | Maintains | $185.00 |
| Mar 9, 2026 | TD Cowen | Charles Rhyee | Buy | Upgrade | $213.00 |
| Mar 6, 2026 | Barclays | Luke Sergott | Overweight | Upgrade | $210.00 |
| Mar 3, 2026 | RBC Capital | Ryan Halsted | Outperform | Initiates | $221.00 |
| Feb 19, 2026 | Truist Securities | Jailendra Singh | Buy | Maintains | $245.00 |
| Feb 6, 2026 | Stifel | Shlomo Rosenbaum | Buy | Maintains | $220.00 |
| Feb 6, 2026 | Barclays | Luke Sergott | Equal-Weight | Maintains | $210.00 |
| Feb 6, 2026 | Citigroup | Patrick Donnelly | Neutral | Maintains | $200.00 |
| Feb 6, 2026 | JP Morgan | Casey Woodring | Overweight | Maintains | $225.00 |
| Feb 6, 2026 | UBS | Dan Leonard | Buy | Maintains | $240.00 |
| Feb 6, 2026 | Jefferies | David Windley | Buy | Maintains | $255.00 |
| Jan 22, 2026 | TD Cowen | Charles Rhyee | Hold | Maintains | $245.00 |
| Jan 8, 2026 | UBS | Dan Leonard | Buy | Maintains | $280.00 |
| Jan 8, 2026 | Truist Securities | Jailendra Singh | Buy | Maintains | $290.00 |
| Dec 2, 2025 | Morgan Stanley | Tejas Savant | Overweight | Maintains | $265.00 |
| Nov 13, 2025 | BMO Capital | Sean Dodge | Outperform | Initiates | $260.00 |
| Nov 3, 2025 | TD Cowen | Charles Rhyee | Hold | Downgrade | $215.00 |
| Oct 29, 2025 | UBS | Dan Leonard | Buy | Maintains | $250.00 |
| Oct 29, 2025 | Baird | Eric Coldwell | Outperform | Upgrade | $258.00 |
| Oct 29, 2025 | Truist Securities | Jailendra Singh | Buy | Reiterates | $265.00 |
IQVIA Holdings Inc. (IQV) Competitors
The following stocks are similar to IQVIA based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
IQVIA Holdings Inc. (IQV) Financial Data
IQVIA Holdings Inc. has a market capitalization of $29.95B with a P/E ratio of 22.5x. The company generates $16.31B in trailing twelve-month revenue with a 8.3% profit margin.
Revenue growth is +10.3% quarter-over-quarter, while maintaining an operating margin of +15.2% and return on equity of +21.4%.
Valuation Metrics
Market Cap
$29.95B
Enterprise Value
$44.24B
P/E Ratio
22.5x
PEG Ratio
0.9x
Price/Sales
1.8x
Growth & Margins
Revenue Growth (YoY)
+10.3%
Gross Margin
+32.9%
Operating Margin
+15.2%
Net Margin
+8.3%
EPS Growth
+17.6%
Financial Health
Cash/Price Ratio
+7.1%
Current Ratio
0.7x
Debt/Equity
245.9x
ROE
+21.4%
ROA
+5.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
IQVIA Holdings Inc. (IQV) Business Model
About IQVIA Holdings Inc.
What They Do
Provides analytics and clinical research services.
Business Model
The company operates through three divisions: Research & Development, Technology & Analytics, and Contract Sales & Medical. It generates revenue by managing clinical trials, offering technology solutions and analytics services, and providing sales and patient engagement services to healthcare providers and pharmaceutical companies.
Additional Information
Founded in 2016 and based in Durham, North Carolina, IQVIA conducts operations in over 100 countries and utilizes its proprietary IQVIA Connected Intelligence™ platform to enhance healthcare solutions, supporting clinical development and commercialization efforts globally.
Company Information
Sector
Healthcare
Industry
Diagnostics & Research
Employees
93,000
CEO
Mr. Ari Bousbib
Country
United States
IPO Year
2013
Website
www.iqvia.comIQVIA Holdings Inc. (IQV) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Here's Why IQVIA Holdings (IQV) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Apr 10, 2026
By Zacks Equity Research
Tale of the Tape
Here's Why IQVIA Holdings (IQV) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Apr 09, 2026
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
IQVIA Holdings Inc. (NYSE:IQV) will release its Q1 2026 financial results on May 5, 2026, before market open, followed by a conference call at 9:00 a.m. ET.
Why It Matters
IQVIA's upcoming earnings report and conference call may impact investor sentiment and stock performance, providing insights into its financial health and future growth prospects.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
In Q1, Artisan Mid Cap Value Fund underperformed the Russell Midcap® Value Index, impacted by momentum-driven market trends. Notable decliners included ICON, Gartner, and Pinterest, each down over 30%. Major new buys were Brown & Brown, Veralto, and IQVIA Holdings.
Why It Matters
The Artisan Mid Cap Value Fund's underperformance against the Russell Midcap® Value Index signals challenges in value investing, impacting fund attractiveness and future investment strategies.
Source: Seeking Alpha
Market Sentiment:
Negative
Quick Summary
Zacks Style Scores can help investors identify strong, market-beating stocks for their portfolios.
Why It Matters
Zacks Style Scores highlight stocks with strong performance potential, guiding investors to make informed choices for higher returns in their portfolios.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
IQVIA's collaboration with NVIDIA on AI and strategic deals boost growth, but declining liquidity may impact near-term financial flexibility.
Why It Matters
IQVIA's AI initiatives and strategic moves signal growth potential, but weakening liquidity may limit financial flexibility, impacting risk assessments and investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Zacks Premium offers Style Scores to help investors identify strong stocks, catering to value, growth, and momentum investment strategies.
Why It Matters
The Zacks Style Scores can enhance stock selection for various investment strategies, potentially improving portfolio performance and guiding investors to high-potential stocks.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
IQVIA Holdings Inc. launched IQVIA.ai, an AI platform aimed at transforming operations in life sciences. The platform integrates clinical, commercial, and real-world insights.
Why It Matters
The launch of IQVIA.ai signals innovation in AI for life sciences, potentially enhancing efficiency and decision-making, which could drive growth and profitability for IQVIA and its clients.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About IQV Stock
What is IQVIA Holdings Inc.'s (IQV) stock forecast for 2026?
Based on our analysis of 44 Wall Street analysts, IQVIA Holdings Inc. (IQV) has a median price target of $229.00. The highest price target is $287.00 and the lowest is $185.00.
Is IQV stock a good investment in 2026?
According to current analyst ratings, IQV has 21 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $176.46. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for IQV stock?
Wall Street analysts predict IQV stock could reach $229.00 in the next 12 months. This represents a 29.8% increase from the current price of $176.46. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is IQVIA Holdings Inc.'s business model?
The company operates through three divisions: Research & Development, Technology & Analytics, and Contract Sales & Medical. It generates revenue by managing clinical trials, offering technology solutions and analytics services, and providing sales and patient engagement services to healthcare providers and pharmaceutical companies.
What is the highest forecasted price for IQV IQVIA Holdings Inc.?
The highest price target for IQV is $287.00 from Luke Sergott at Barclays, which represents a 62.6% increase from the current price of $176.46.
What is the lowest forecasted price for IQV IQVIA Holdings Inc.?
The lowest price target for IQV is $185.00 from Elizabeth Anderson at Evercore ISI Group, which represents a 4.8% increase from the current price of $176.46.
What is the overall IQV consensus from analysts for IQVIA Holdings Inc.?
The overall analyst consensus for IQV is bullish. Out of 44 Wall Street analysts, 21 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $229.00.
How accurate are IQV stock price projections?
Stock price projections, including those for IQVIA Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 20, 2026 3:43 PM UTC